Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

SAN DIEGO, Aug. 3, 2022 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its first quarter ended June 30, 2022, at 4:15 p.m. EST…

Click here to view original post